Company
TNYA · CIK 0001858848
Acquisition (code A) of 49,000 shares at $0 per share.
Reporting Person Tingley Whittemore · Officer Title Chief Medical Officer · Transaction Code A
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001193125-26-389561 · filed 2026-09-11 · View filing →
Acquisition (code A) of 122,000 shares at $0 per share.
Reporting Person Ali Faraz · Officer Title Chief Executive Officer · Transaction Code A
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001193125-26-389563 · filed 2026-09-11 · View filing →
Sale of 1,637 shares at $0.7098 per share.
Reporting Person Tingley Whittemore · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354517 · filed 2026-08-17 · View filing →
Sale of 1,637 shares at $0.7098 per share.
Reporting Person Tingley Whittemore · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354517 · filed 2026-08-17 · View filing →
Sale of 1,871 shares at $0.7098 per share.
Reporting Person Tingley Whittemore · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354517 · filed 2026-08-17 · View filing →
Sale of 2,279 shares at $0.7098 per share.
Reporting Person Tingley Whittemore · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354517 · filed 2026-08-17 · View filing →
Sale of 5,837 shares at $0.7097 per share.
Reporting Person Ali Faraz · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354518 · filed 2026-08-17 · View filing →
Sale of 3,969 shares at $0.7098 per share.
Reporting Person Ali Faraz · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354518 · filed 2026-08-17 · View filing →
Sale of 5,020 shares at $0.7097 per share.
Reporting Person Ali Faraz · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354518 · filed 2026-08-17 · View filing →
Sale of 7,406 shares at $0.7097 per share.
Reporting Person Ali Faraz · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354518 · filed 2026-08-17 · View filing →